Which has higher immunization, hib3, Iran or Latin America & Caribbean?

Iran, at 98.0% against 81.8% in Latin America & Caribbean as of 2024.

How many years of comparable data are there for Iran and Latin America & Caribbean?

10 years are reported by both, from 2015 to 2024.

Where does this data come from?

WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Iran vs Latin America & Caribbean: Immunization, Hib3

Iran

98.0%

in 2024

Latin America & Caribbean

81.8%

in 2024

Iran rank

20th

Latin America & Caribbean rank

22nd

Immunization, Hib3 over time

Iran
Latin America & Caribbean

How they compare

Iran currently reports 98.0% against 81.8% in Latin America & Caribbean, a difference of 16.2%.

That makes Iran's figure about 1.2 times Latin America & Caribbean's.

Across all 10 years both countries report, Iran has been ahead every year.

Iran ranks 20th and Latin America & Caribbean ranks 22nd of 191 countries.

Iran has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade	Iran	Latin America & Caribbean	Difference	Ahead
2010s	98.8%	85.4%	13.4%	Iran
2020s	98.6%	79.0%	19.6%	Iran

Averages of every year both report within each decade.

Frequently asked questions

Which has higher immunization, hib3, Iran or Latin America & Caribbean?: Iran, at 98.0% against 81.8% in Latin America & Caribbean as of 2024.
What is the difference in immunization, hib3 between Iran and Latin America & Caribbean?: 16.2%, with Iran ahead.
How many years of comparable data are there for Iran and Latin America & Caribbean?: 10 years are reported by both, from 2015 to 2024.
How do Iran and Latin America & Caribbean rank globally for immunization, hib3?: Iran ranks 20th and Latin America & Caribbean ranks 22nd of 191 countries.
Where does this data come from?: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Iran vs Latin America & Caribbean: Immunization, Hib3. Statizoid, drawing on WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Retrieved 17 September 2026, from https://health.statizoid.com/compare/immunization-hib3-percent-of-children-ages-12-23-months/iran-islamic-rep/latin-america-and-caribbean/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/immunization-hib3-percent-of-children-ages-12-23-months/iran-islamic-rep/latin-america-and-caribbean/">Iran vs Latin America & Caribbean: Immunization, Hib3</a> — Statizoid

About this data

Indicator: Immunization, Hib3 (% of children ages 12-23 months)
Unit: % of children ages 12-23 months
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/)
Licence: CC BY 4.0 (World Bank Open Data)
Coverage: 234 places, 5,441 data points, 1990–2024
Last refreshed: 17 September 2026

Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.